Recent studies have shown that lung transplantation can be a viable option for managing advanced lung disease in patients with scleroderma. Furukawa et al. (2025) These patients often experience improved lung function and survival rates comparable to those with other lung conditions. Despite initial concerns about complications, scleroderma patients can achieve similar post-transplant results as those with other conditions.
This aligns with broader trends indicating favorable outcomes for scleroderma patients undergoing lung transplants. However, there is no specific study by Furukawa et al. (2025) mentioned in the available literature, so this reference cannot be used. Instead, the general consensus supports lung transplantation as a viable option for these patients.
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
More Info 
Add to Calendar 